Givaudan stock holds after 2025 sales growth and margin pressure
Published on 07/23/2026 at 20:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Givaudan stock is anchored by full-year 2025 sales of CHF 7.41 billion, net profit of CHF 936 million, and a free cash flow conversion rate of 94.9% in 2025. The Swiss flavor and fragrance group also reported a comparable sales rise of 5.7% for 2025, giving investors a dated operating base to measure the shares against.
2025 sales up 5.7%
For 2025, Givaudan reported sales of CHF 7.41 billion, up 5.7% on a comparable basis, with the company pointing to broad-based demand across its portfolio. The same year, net profit reached CHF 936 million, compared with CHF 893 million in 2024, a year-on-year increase of 4.8%.
That combination matters because the profit line grew more slowly than sales, which points to margin discipline rather than a simple revenue rebound. The market still has to price that gap against the companys cash generation, which remained strong at a 94.9% free cash flow conversion rate in 2025.
Cash generation stayed high
Givaudan also reported free cash flow of CHF 886 million in 2025, up from CHF 817 million in 2024. Net income attributable to shareholders of the company was CHF 936 million in 2025, and basic earnings per share came in at CHF 101.03, compared with CHF 96.83 in 2024.
Those figures show that the business remained highly cash generative even after a year of moderate profit growth. For investors, the mix of CHF 7.41 billion in sales, CHF 886 million in free cash flow, and CHF 101.03 in EPS is the key numerical set, not a one-off event headline.
Givaudan 2025 annual report and investor materials
The latest annual report provides the full 2025 operating picture, including sales, profit, cash flow, and balance-sheet detail.
Sales mix still matters
The company said its Taste & Wellbeing division and Fragrance & Beauty division both contributed to the 2025 base, with portfolio breadth still central to the story. In practical terms, the 5.7% comparable sales increase and the CHF 94.9% free cash flow conversion rate show that growth and liquidity remained aligned in 2025.
That is the part investors usually watch most closely for a consumer ingredients group: whether volume and price growth are translating into cash. In Givaudan's case, the 2025 numbers indicate that they did.
Fragrance and taste products
Within its product mix, Givaudan continues to rely on fragrance and taste applications for food, beverages, personal care, and home care customers. The 2025 report shows that the company still monetized that mix at scale, with CHF 7.41 billion in sales and CHF 936 million in net profit.
Stock level and valuation
The share price line is omitted here because no dated market quote is available in the current article set, so the clearest market anchor remains the 2025 report metrics. For a Swiss blue-chip consumer ingredients group, the combination of 5.7% comparable sales growth, CHF 886 million in free cash flow, and CHF 101.03 in EPS is the freshest numerical reference point.
Givaudan company snapshot
- Company: Givaudan SA
- ISIN: CH0010645932
- Ticker: SIX: GIVN
- Trading venue: SIX Swiss Exchange
- Sector / Industry: Consumer Staples / Specialty Chemicals
- Index membership: SMI
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
